ABT
Price
$113.47
Change
+$1.96 (+1.76%)
Updated
Mar 27, 6:59 PM EST
20 days until earnings call
BSX
Price
$68.65
Change
+$0.70 (+1.03%)
Updated
Mar 27, 6:59 PM EST
27 days until earnings call
Ad is loading...

ABT vs BSX ᐉ Comparison: Which is Better to Invest?

Header iconABT vs BSX Comparison
Open Charts ABT vs BSXBanner chart's image
Abbott Laboratories
Price$113.47
Change+$1.96 (+1.76%)
Volume$2.29M
CapitalizationN/A
Boston Scientific
Price$68.65
Change+$0.70 (+1.03%)
Volume$1.2M
CapitalizationN/A
View a ticker or compare two or three
ABT vs BSX Comparison Chart

Loading...

ABTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BSXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ABT vs. BSX commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a StrongBuy and BSX is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (ABT: $113.48 vs. BSX: $68.62)
Brand notoriety: ABT and BSX are both notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ABT: 126% vs. BSX: 63%
Market capitalization -- ABT: $196.91B vs. BSX: $100.86B
ABT [@Medical Specialties] is valued at $196.91B. BSX’s [@Medical Specialties] market capitalization is $100.86B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 3 FA rating(s) are green whileBSX’s FA Score has 2 green FA rating(s).

  • ABT’s FA Score: 3 green, 2 red.
  • BSX’s FA Score: 2 green, 3 red.
According to our system of comparison, ABT is a better buy in the long-term than BSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 5 TA indicator(s) are bullish while BSX’s TA Score has 3 bullish TA indicator(s).

  • ABT’s TA Score: 5 bullish, 5 bearish.
  • BSX’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, ABT is a better buy in the short-term than BSX.

Price Growth

ABT (@Medical Specialties) experienced а +1.78% price change this week, while BSX (@Medical Specialties) price change was +1.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.09%. For the same industry, the average monthly price growth was -0.31%, and the average quarterly price growth was +3.80%.

Reported Earning Dates

ABT is expected to report earnings on Apr 17, 2024.

BSX is expected to report earnings on Apr 24, 2024.

Industries' Descriptions

@Medical Specialties (+1.09% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ABT with price predictions.
OPEN
A.I.dvisor published
a Summary for BSX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ABT($197B) has a higher market cap than BSX($101B). BSX has higher P/E ratio than ABT: BSX (64.13) vs ABT (34.81). BSX YTD gains are higher at: 18.699 vs. ABT (3.596). ABT has higher annual earnings (EBITDA): 10.5B vs. BSX (3.45B). ABT has more cash in the bank: 7.28B vs. BSX (865M). BSX has less debt than ABT: BSX (9.49B) vs ABT (15.6B). ABT has higher revenues than BSX: ABT (40.1B) vs BSX (14.2B).
ABTBSXABT / BSX
Capitalization197B101B195%
EBITDA10.5B3.45B305%
Gain YTD3.59618.69919%
P/E Ratio34.8164.1354%
Revenue40.1B14.2B282%
Total Cash7.28B865M842%
Total Debt15.6B9.49B164%
FUNDAMENTALS RATINGS
ABT vs BSX: Fundamental Ratings
ABT
BSX
OUTLOOK RATING
1..100
5771
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
81
Overvalued
PROFIT vs RISK RATING
1..100
3319
SMR RATING
1..100
5876
PRICE GROWTH RATING
1..100
5117
P/E GROWTH RATING
1..100
2988
SEASONALITY SCORE
1..100
6585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (13) in the Medical Specialties industry is significantly better than the same rating for BSX (81). This means that ABT’s stock grew significantly faster than BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (19) in the Medical Specialties industry is in the same range as ABT (33). This means that BSX’s stock grew similarly to ABT’s over the last 12 months.

ABT's SMR Rating (58) in the Medical Specialties industry is in the same range as BSX (76). This means that ABT’s stock grew similarly to BSX’s over the last 12 months.

BSX's Price Growth Rating (17) in the Medical Specialties industry is somewhat better than the same rating for ABT (51). This means that BSX’s stock grew somewhat faster than ABT’s over the last 12 months.

ABT's P/E Growth Rating (29) in the Medical Specialties industry is somewhat better than the same rating for BSX (88). This means that ABT’s stock grew somewhat faster than BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTBSX
RSI
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
57%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
48%
Bearish Trend 1 day ago
51%
Momentum
ODDS (%)
Bearish Trend 1 day ago
47%
Bullish Trend 1 day ago
56%
MACD
ODDS (%)
Bearish Trend 1 day ago
49%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
60%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
51%
Bullish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 1 day ago
57%
Bullish Trend 1 day ago
60%
Declines
ODDS (%)
Bearish Trend 4 days ago
53%
Bearish Trend 18 days ago
49%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
61%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
60%
View a ticker or compare two or three
Ad is loading...
ABTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
BSXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZNTL15.211.12
+7.95%
Zentalis Pharmaceuticals
SGHT5.180.15
+3.00%
Sight Sciences
RUSHB52.921.34
+2.60%
Rush Enterprises
CSGP96.251.07
+1.12%
CoStar Group
SQNS0.40N/A
N/A
Sequans Communications SA

ABT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABT has been closely correlated with IDXX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if ABT jumps, then IDXX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABT
1D Price
Change %
ABT100%
+1.78%
IDXX - ABT
66%
Closely correlated
+1.70%
MDT - ABT
61%
Loosely correlated
+3.85%
BAX - ABT
54%
Loosely correlated
+2.77%
SYK - ABT
52%
Loosely correlated
+2.61%
ZBH - ABT
50%
Loosely correlated
+3.90%
More

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with SYK. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+1.00%
SYK - BSX
67%
Closely correlated
+2.61%
RVTY - BSX
52%
Loosely correlated
+1.92%
ISRG - BSX
51%
Loosely correlated
+0.66%
ZBH - BSX
51%
Loosely correlated
+3.90%
ABT - BSX
45%
Loosely correlated
+1.78%
More